VISKEN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Visken, and what generic alternatives are available?
Visken is a drug marketed by Novartis and is included in one NDA.
The generic ingredient in VISKEN is pindolol. There are eleven drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the pindolol profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Visken
A generic version of VISKEN was approved as pindolol by AUROBINDO PHARMA USA on September 3rd, 1992.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for VISKEN?
- What are the global sales for VISKEN?
- What is Average Wholesale Price for VISKEN?
Summary for VISKEN
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 78 |
Clinical Trials: | 2 |
Patent Applications: | 4,279 |
DailyMed Link: | VISKEN at DailyMed |
Recent Clinical Trials for VISKEN
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
University of Ottawa | Phase 1 |
Novartis | N/A |
Danish Heart Foundation | N/A |
US Patents and Regulatory Information for VISKEN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Novartis | VISKEN | pindolol | TABLET;ORAL | 018285-001 | Sep 3, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Novartis | VISKEN | pindolol | TABLET;ORAL | 018285-002 | Sep 3, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for VISKEN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Novartis | VISKEN | pindolol | TABLET;ORAL | 018285-001 | Sep 3, 1982 | ⤷ Sign Up | ⤷ Sign Up |
Novartis | VISKEN | pindolol | TABLET;ORAL | 018285-002 | Sep 3, 1982 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for VISKEN
See the table below for patents covering VISKEN around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Germany | 1620342 | ⤷ Sign Up | |
Sweden | 340621 | ⤷ Sign Up | |
France | 353 | ⤷ Sign Up | |
Austria | 303025 | ⤷ Sign Up | |
Switzerland | 495983 | Verfahren zur Herstellung von linksdrehendem 4-(2-Hydroxy-3-isopropylaminopropoxy)indol | ⤷ Sign Up |
>Country | >Patent Number | >Title | >Estimated Expiration |